MedPath

VACCINATION ADJUVED AGAINST HEPATITIS B IN SACYL WORKERS TYPED AS NO RESPONDERS TO CONVENTIONAL VACCINES

Phase 1
Conditions
Health workers with biological risk in their tasks, who have been vaccinated as non-responders to conventional vaccination against Hepatitis B
Therapeutic area: Body processes [G] - Immune system processes [G12]
Registration Number
EUCTR2016-004991-23-ES
Lead Sponsor
IBSAL (Instituto de Investigación Biomédica de Salamanca)-Fundación Instituto de Estudios de Ciencias de la Salud de
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
47
Inclusion Criteria

Health workers in the Health Area of ??Salamanca, Zamora, Leon, Valladolid and Palencia
Criteria defining them as NO responders to the conventional hepatitis B vaccine: anti HBsAb titers <10 mIU / ml following the application of six doses of conventional vaccine at 20 µg doses (two complete guidelines)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 47
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Known allergy to the active substance or any of the other ingredients of the medicinal product (included in section 6 of the product data sheet).
If you have ever had an allergic reaction to any vaccine against hepatitis B
If you have a serious infection with fever.
Subjects for whom informed consent is not obtained
Subjects that have not revoked the consent initially signed.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath